Found vs Hims & Hers: Cash-Pay GLP-1 Options Compared Head-to-Head

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found and Hims & Hers both offer cash-pay compounded GLP-1 programs, but their pricing structures differ sharply. Found's cash-pay track starts at $289/month for semaglutide on a rolling 4-week cycle (13 charges per year, $3,757 annually) or $169/month if you prepay $2,028 for a 12-month supply upfront. Hims & Hers advertises $199/month for compounded semaglutide, but that rate requires a 6-month prepayment of $1,194 ($2,388 over 12 months if you renew); we found no verified standard monthly-billed option at the time of capture (September 4, 2026). PlexusDx offers compounded semaglutide injection at $189 month-to-month with calendar-month billing (12 charges per year, $2,268 annually), $169/month on a 3-month commitment ($2,028 annually), or $149/month on a 6-month commitment ($1,788 annually)—all billed in installments, not as lump-sum prepayments.

If you want the lowest 12-month cost and can prepay, Found's $2,028 annual plan ties PlexusDx's 3-month rate over a year, though Found locks the full amount upfront. If you prefer month-to-month flexibility with no prepayment, PlexusDx's $189 month-to-month sits between Hims & Hers' prepaid-only $199 and Found's standard $289 monthly rate. For tirzepatide, Found offers verified cash pricing ($359 month-to-month, $239 on a 12-month prepay); Hims & Hers tirzepatide cash pricing was not captured in our sources. Both competitors offer broader service wraps—Found provides 24/7 care team access and an app-based program; Hims & Hers bundles clinical access with medication—while PlexusDx includes a free Doctor of Pharmacy check-in and optional genetic drug-response testing ($99 for program members, $298 standalone) but operates a leaner model.

At-a-glance comparison

Sources: Found pricing verified July 20, 2026 and captured September 4, 2026; Hims & Hers pricing captured September 4, 2026; PlexusDx pricing verified July 20, 2026. All 12-month totals are our calculations.

Like-for-like pricing: month-to-month and prepaid plans

Month-to-month compounded semaglutide

PlexusDx charges $189 per calendar month (12 charges per year, $2,268 annually). Found's standard cash-pay rate is $289 per month, billed every 4 weeks, which produces 13 billing cycles in a 52-week year and an annual cost of $3,757 (our calculation). Hims & Hers did not offer a verified standard monthly-billed option at the time of capture; the only verified rate was the 6-month prepaid plan described below. If you want true month-to-month flexibility—pay-as-you-go with no upfront lump sum—PlexusDx is $100/month less than Found's standard rate, and Hims & Hers does not appear to offer it.

Prepaid semaglutide: upfront commitment vs installment commitment

Found's 12-month cash-pay plan advertises a $169/month rate but requires $2,028 paid upfront for the full year (verified July 20, 2026 and captured September 4, 2026). Hims & Hers advertises $199/month with a 6-month prepayment of $1,194 (captured September 4, 2026); two cycles cost $2,388 over 12 months (our calculation). PlexusDx offers a 3-month rate of $169/month and a 6-month rate of $149/month, both billed in monthly installments rather than as lump-sum prepayments—$2,028 and $1,788 over 12 months, respectively (our calculations).

Comparing 12-month costs on the lowest available rate: PlexusDx's 6-month commitment delivers $1,788 annually; Found's 12-month prepay is $2,028; Hims & Hers' repeated 6-month prepays total $2,388. PlexusDx's 3-month rate ($2,028 annually) ties Found's 12-month prepay dollar-for-dollar, but PlexusDx bills in $169 monthly installments while Found requires the full $2,028 upfront.

Compounded tirzepatide

Found offers compounded tirzepatide at $359/month on a standard 4-week cycle (13 charges, $4,667 annually; our calculation) or $239/month on a 12-month prepaid plan (calculated $2,868 upfront). PlexusDx charges $289 month-to-month ($3,468 annually; our calculation) or $249/month on a 6-month commitment ($2,988 annually; our calculation). Hims & Hers tirzepatide cash pricing was not verified in our sources; readers should confirm availability and cost at checkout.

Over 12 months, PlexusDx's 6-month tirzepatide rate ($2,988) sits between Found's 12-month prepay ($2,868) and Found's standard monthly cycle ($4,667). Found holds the lowest 12-month tirzepatide cost if you prepay the full year upfront; PlexusDx offers a lower monthly rate than Found's standard cycle and bills in installments rather than requiring a lump sum.

Decision factors: service model, support, and flexibility

Upfront capital vs monthly cash flow

Found's lowest advertised rate—$169/month for semaglutide—requires $2,028 paid upfront for a full year. Hims & Hers' $199/month rate locks $1,194 for six months, and renewing for a second cycle costs another $1,194 ($2,388 over 12 months). PlexusDx's 3-month and 6-month commitments bill monthly installments rather than lump-sum prepayments: the 3-month rate is $169/month (identical per-month cost to Found's 12-month plan but billed $169 at a time), and the 6-month rate is $149/month. If you want the economic benefit of a commitment plan but prefer to manage monthly cash flow rather than park $2,000+ upfront, PlexusDx's installment structure may fit better. If you can prepay and want the absolute lowest 12-month total for semaglutide, PlexusDx's 6-month rate ($1,788 annually) edges both competitors; for tirzepatide, Found's 12-month prepay ($2,868) is lower than PlexusDx's 6-month rate ($2,988) by $120 over the year.

Month-to-month flexibility

PlexusDx's month-to-month semaglutide rate is $189 (calendar month, 12 charges per year). Found's standard cash-pay rate is $289 every 4 weeks (13 charges per year). Hims & Hers did not offer a verified month-to-month option; the only captured rate required 6-month prepayment. If you are testing GLP-1 therapy, unwilling to commit capital upfront, or want the freedom to stop or switch without forfeiting a prepaid balance, PlexusDx and Found both offer rolling monthly options, with PlexusDx $100/month lower. For tirzepatide month-to-month, PlexusDx is $289 and Found is $359; again PlexusDx is $70/month less, but neither requires prepayment on the monthly track.

Service wrap and care team access

Found bundles 24/7 care team access and an app-based program into its cash-pay price; the company positions itself as a comprehensive weight-loss program rather than medication-only. Hims & Hers includes clinical access with medication; the scope and availability of that access were not detailed in the sources we reviewed (readers should confirm at intake). PlexusDx includes a free Doctor of Pharmacy check-in with every medication order and offers an optional genetic drug-response testing add-on ($99 for program members, $298 standalone) but does not bundle ongoing coaching, an app, or 24/7 messaging. If you want integrated behavioral support, meal planning, or round-the-clock care team availability, Found's model may justify its higher standard rate. If you prefer self-directed medication management with clinical oversight on demand, PlexusDx's leaner model costs less.

Refund and cancellation policies

Found grants a full refund if you are not clinically eligible and allows cancellation anytime through its app (verified July 20, 2026). Hims & Hers refund and cancellation terms were not captured in our sources; prospective patients should review those policies during intake. PlexusDx follows standard telehealth refund practice (refund if not clinically eligible) and allows cancellation of ongoing subscriptions without penalty. If you prepay a multi-month plan with any provider, confirm whether unused months are prorated or forfeited upon cancellation.

Review and reputation signals

Hims & Hers had 10,094 Trustpilot reviews at the time of capture (September 4, 2026); the aggregate rating was not captured, but the volume reflects a large established user base. Negative Reddit themes captured in our sources included reports of delayed or lost shipments, inconsistent prescription renewals, and customer service responsiveness concerns; these are individual allegations and anecdotes—readers should review current Trustpilot and Reddit discussions and weigh them against the platform's scale. Found holds a 4.1-star Trustpilot rating with approximately 732 reviews (captured September 4, 2026); no dominant negative theme was captured in our research. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). All three providers operate within a similar ratings band; volume and sentiment vary, and prospective patients should read recent reviews on Trustpilot and independent forums before committing to a multi-month prepaid plan.

Choose Found if…

• You want an app-based program with 24/7 care team access, messaging, and behavioral support bundled into the price.
• You can prepay $2,028 upfront for semaglutide (12-month plan) or $2,868 for tirzepatide and want the lowest per-month rate Found offers.
• You prefer a 4-week billing cycle rather than calendar-month billing.
• You value HSA/FSA payment eligibility (Found cash-pay plans are HSA/FSA eligible; verify with your account administrator).
• You want explicit in-app cancellation and a documented full-refund policy if you are not clinically eligible.

Choose Hims & Hers if…

• You are comfortable with a 6-month prepayment ($1,194 for semaglutide) and want the $199/month rate that structure delivers.
• You already use Hims & Hers for other health services and prefer to consolidate care under one account.
• You want bundled clinical access with medication and are willing to confirm at intake what that access includes (visit frequency, messaging availability, etc.).
• You prioritize a large established provider with high review volume; verify current Trustpilot sentiment and confirm refund/cancellation terms before prepaying.

Note: Hims & Hers tirzepatide cash pricing was not verified in our sources. If tirzepatide is your target compound, confirm availability and cost during your intake.

Choose PlexusDx if…

• You want true month-to-month flexibility at $189 for semaglutide or $289 for tirzepatide, with no upfront lump-sum prepayment required.
• You prefer installment billing over lump-sum prepayment: PlexusDx's 3-month rate ($169/month) matches Found's 12-month prepay per-month cost but bills monthly, and the 6-month rate ($149 semaglutide, $249 tirzepatide) delivers the lowest 12-month cost in this comparison without requiring thousands of dollars upfront.
• You value genetic drug-response insights and want the option to add genetic testing ($99 for program members) to guide compound and dose selection.
• You prefer a leaner service model—medication and clinical oversight without bundled coaching or app-based programming—and want that simplicity reflected in the price.
• You want a provider with a verified Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher) and transparent evidence-based content practices (PlexusDx publishes the methodology and capture dates behind every comparison).

Methodology and freshness

This comparison is based on publicly available pricing, product pages, and checkout flows captured between July 20, 2026 and September 6, 2026. Found pricing was verified on July 20, 2026 and confirmed via checkout capture on September 4, 2026. Hims & Hers pricing was captured on September 4, 2026; the 6-month prepaid semaglutide plan was verified, but no standard month-to-month rate or tirzepatide cash rate was found in our sources at that date. PlexusDx pricing was verified on July 20, 2026. Trustpilot ratings were captured on September 4, 2026 (Hims & Hers review count and negative Reddit themes; Found 4.1 stars, ~732 reviews; PlexusDx 4.3 stars, rating distribution). All 12-month cost totals and effective monthly rates are our calculations derived from the verified per-month figures and billing frequencies. Readers should confirm current pricing, prepayment requirements, refund policies, and medication availability during intake; telehealth pricing and formulary access can change, and eligibility is determined by a licensed clinician on an individual basis.

Frequently Asked Questions

Does Hims & Hers offer a month-to-month semaglutide plan?

We did not find a verified month-to-month option for Hims & Hers compounded semaglutide in our September 4, 2026 capture; the only verified rate was $199/month with a 6-month prepayment of $1,194. Confirm current billing options during your intake.

Can I use HSA or FSA funds for Found's cash-pay plans?

Yes. Found's cash-pay GLP-1 plans are documented as HSA/FSA eligible (verified July 20, 2026). Verify eligibility with your account administrator before purchasing, as HSA/FSA rules vary by plan and employer.

How do PlexusDx's 3-month and 6-month commitments work?

PlexusDx bills the committed rate each calendar month rather than requiring a lump-sum prepayment. The 3-month rate is $169/month for semaglutide, billed monthly for three months, then renews or converts to month-to-month. The 6-month rate is $149/month, billed monthly for six months. This structure spreads the cost into monthly installments instead of a single upfront charge.

Which provider has the lowest 12-month cost for tirzepatide?

Found's 12-month prepaid tirzepatide plan costs $2,868 upfront (calculated from $239/month × 12), which is $120 less over a year than PlexusDx's 6-month rate ($2,988, calculated from $249/month × 12). Hims & Hers tirzepatide cash pricing was not verified. If you can prepay the full year, Found delivers the lowest annual total for tirzepatide among the providers we reviewed.

What happens if I'm not clinically eligible after paying?

Found grants a full refund if you are not clinically eligible (verified July 20, 2026). Hims & Hers refund terms were not captured; confirm during intake. PlexusDx follows standard telehealth practice and refunds patients who are not clinically eligible. No provider charges until a licensed clinician approves your prescription.

Sources

• Found pricing and service details verified July 20, 2026 and captured September 4, 2026 via public product pages and checkout flow.
• Found insurance plan pricing captured September 6, 2026 via public product pages.
• Hims & Hers pricing captured September 4, 2026 via public product pages and checkout flow.
• PlexusDx pricing verified July 20, 2026; service details verified July 17–23, 2026.
• Trustpilot ratings: Hims & Hers review count, Found 4.1-star rating (~732 reviews), and PlexusDx 4.3-star rating (79% five-star, 83% four-star or higher) all captured September 9, 2026.
• Reddit negative themes for Hims & Hers captured September 4, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.